Project cooperationUpdated on 29 December 2025
2) HORIZON-HLTH-2026-01-IND-03 – Regulatory science to support translational development of patient-centred health technologies
COO at Submed
Tekirdağ, Türkiye
About
SUBMED can contribute through its expertise in ISO 13485 quality management systems, product lifecycle management, sterilisation and validation, and preclinical evidence generation, providing an industrial regulatory science perspective. Within the project, SUBMED can deliver real-world industrial case studies illustrating how innovative patient-centred health technologies can be optimised for regulatory compliance, risk management and patient safety from early R&D stages through to market access. Its contribution will focus on translating regulatory science concepts into practical, implementable approaches that are directly relevant to industry and regulatory stakeholders.
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
1) HORIZON-HLTH-2026-01-TOOL-03 – Integrating New Approach Methodologies (NAMs)
- Partner seeks Consortium/Coordinator
Murat YILDIRIM
COO at Submed
Tekirdağ, Türkiye
Project cooperation
- Partner seeks Consortium/Coordinator
Murat YILDIRIM
COO at Submed
Tekirdağ, Türkiye
Project cooperation
Regulatory and Quality Strategy Partner
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-05: Support for a multilateral initiative on climate change and health research
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-04: Towards climate resilient, prepared and carbon neutral populations and healthcare systems
- DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
- DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Katja Koskinen
CEO at Nometech Oy
Oulu, Finland